Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.
Delphi process
Hypopituitarism
Perioperative
Pituitary adenoma
Postoperative assessment
Transsphenoidal surgery
Journal
Pituitary
ISSN: 1573-7403
Titre abrégé: Pituitary
Pays: United States
ID NLM: 9814578
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
accepted:
01
07
2021
pubmed:
21
7
2021
medline:
10
2
2022
entrez:
20
7
2021
Statut:
ppublish
Résumé
In adults and children, transsphenoidal surgery (TSS) represents the cornerstone of management for most large or functioning sellar lesions with the exception of prolactinomas. Endocrine evaluation and management are an essential part of perioperative care. However, the details of endocrine assessment and care are not universally agreed upon. To build consensus on the endocrine evaluation and management of adults undergoing TSS, a Delphi process was used. Thirty-five statements were developed by the Pituitary Society's Education Committee. Fifty-five pituitary endocrinologists, all members of the Pituitary Society, were invited to participate in two Delphi rounds and rate their extent of agreement with statements pertaining to perioperative endocrine evaluation and management, using a Likert-type scale. Anonymized data on the proportion of panelists' agreeing with each item were summarized. A list of items that achieved consensus, based on predefined criteria, was tabulated. Strong consensus (≥ 80% of panelists rating their agreement as 6-7 on a scale from 1 to 7) was achieved for 68.6% (24/35) items. If less strict agreement criteria were applied (ratings 5-7 on the Likert-type scale), consensus was achieved for 88% (31/35) items. We achieved consensus on a large majority of items pertaining to perioperative endocrine evaluation and management using a Delphi process. This provides an international real-world clinical perspective from an expert group and facilitates a framework for future guideline development. Some of the items for which consensus was not reached, including the assessment of immediate postoperative remission in acromegaly or Cushing's disease, represent areas where further research is needed.
Identifiants
pubmed: 34283370
doi: 10.1007/s11102-021-01170-3
pii: 10.1007/s11102-021-01170-3
pmc: PMC8294287
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
64-73Investigateurs
Irina Bancos
(I)
Martin Bidlingmaier
(M)
Nienke Biermasz
(N)
Cesar Luiz Boguszewski
(CL)
Jessica Brzana
(J)
John Carmichael
(J)
Philippe Chanson
(P)
Andjela Drincic
(A)
Yuval Eisenberg
(Y)
Hidenori Fukuoka
(H)
Monica Gadelha
(M)
Luma Ghalib
(L)
Murray Gordon
(M)
Yona Greenman
(Y)
Francisco Guarda
(F)
Miguel Hinojosa-Amaya
(M)
Ken Ho
(K)
Mirela-Diana Ilie
(MD)
Niki Karavitaki
(N)
Larry Katznelson
(L)
Fahrettin Keleştimur
(F)
Andre Lacroix
(A)
Fabienne Langlois
(F)
Dawn Lim
(D)
Sebastian Neggers
(S)
Dan Niculescu
(D)
Stephan Petersenn
(S)
Rosario Pivonello
(R)
Gerald Raverot
(G)
Richard Ross
(R)
Roberto Salvatori
(R)
Carla Scaroni
(C)
Ismat Shafiq
(I)
Susmeeta Sharma
(S)
Antoine Tabarin
(A)
Stylianos Tsagarakis
(S)
Elena Valassi
(E)
Greisa Vila
(G)
Maggie Wierman
(M)
Informations de copyright
© 2021. The Author(s).
Références
Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382(10):937–950. https://doi.org/10.1056/NEJMra1810772
doi: 10.1056/NEJMra1810772
pubmed: 32130815
Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5):516–524. https://doi.org/10.1001/jama.2016.19699
doi: 10.1001/jama.2016.19699
pubmed: 28170483
Valassi E, Biller BM, Klibanski A, Swearingen B (2010) Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol (Oxf) 73(6):798–807. https://doi.org/10.1111/j.1365-2265.2010.03881.x
doi: 10.1111/j.1365-2265.2010.03881.x
Freda PU, Post KD (1999) Differential diagnosis of sellar masses. Endocrinol Metab Clin N Am 28(1):81–117. https://doi.org/10.1016/s0889-8529(05)70058-x
doi: 10.1016/s0889-8529(05)70058-x
Fleseriu M, Bodach ME, Tumialan LM, Bonert V, Oyesiku NM, Patil CG et al (2016) Congress of neurological surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4):E527–E529. https://doi.org/10.1227/NEU.0000000000001387
doi: 10.1227/NEU.0000000000001387
pubmed: 27635959
Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM et al (2016) Congress of neurological surgeons systematic review and evidence-based guideline on posttreatment follow-up evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4):E541–E543. https://doi.org/10.1227/NEU.0000000000001392
doi: 10.1227/NEU.0000000000001392
pubmed: 27635964
Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65(2):265–273. https://doi.org/10.1111/j.1365-2265.2006.02562.x
doi: 10.1111/j.1365-2265.2006.02562.x
Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(2):273–288. https://doi.org/10.1210/jc.2010-1692
doi: 10.1210/jc.2010-1692
pubmed: 21296991
pmcid: 21296991
Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J et al (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 93(7):2454–2462. https://doi.org/10.1210/jc.2007-2734
doi: 10.1210/jc.2007-2734
pubmed: 18413427
pmcid: 3214276
Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO et al (2015) Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807–2831. https://doi.org/10.1210/jc.2015-1818
doi: 10.1210/jc.2015-1818
pubmed: 26222757
pmcid: 4525003
Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM et al (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526–1540. https://doi.org/10.1210/jc.2008-0125
doi: 10.1210/jc.2008-0125
pubmed: 18334580
pmcid: 2386281
Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951. https://doi.org/10.1210/jc.2014-2700
doi: 10.1210/jc.2014-2700
pubmed: 25356808
pmcid: 25356808
Hasson F, Keeney S, McKenna H (2000) Research guidelines for the Delphi survey technique. J Adv Nurs 32(4):1008–1015
pubmed: 11095242
pmcid: 11095242
Keeney S, Hasson F, McKenna HP (2001) A critical review of the Delphi technique as a research methodology for nursing. Int J Nurs Stud 38(2):195–200. https://doi.org/10.1016/s0020-7489(00)00044-4
doi: 10.1016/s0020-7489(00)00044-4
pubmed: 11223060
Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C (2011) Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS ONE 6(6):e20476. https://doi.org/10.1371/journal.pone.0020476
doi: 10.1371/journal.pone.0020476
pubmed: 21694759
pmcid: 3111406
Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD et al (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(4):894–904. https://doi.org/10.1210/jc.2010-1048
doi: 10.1210/jc.2010-1048
pubmed: 21474686
pmcid: 5393422
Langlois F, Woltjer R, Cetas JS, Fleseriu M (2018) Silent somatotroph pituitary adenomas: an update. Pituitary 21(2):194–202. https://doi.org/10.1007/s11102-017-0858-y
doi: 10.1007/s11102-017-0858-y
pubmed: 29305680
Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R et al (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(11):3888–3921. https://doi.org/10.1210/jc.2016-2118
doi: 10.1210/jc.2016-2118
pubmed: 27736313
Haddad RA, Giacherio D, Barkan AL (2019) Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations. Clin Diabetes Endocrinol 5:12. https://doi.org/10.1186/s40842-019-0086-7
doi: 10.1186/s40842-019-0086-7
pubmed: 31367466
pmcid: 6657094
Schofl C, Schofl-Siegert B, Karstens JH, Bremer M, Lenarz T, Cuarezma JS et al (2002) Falsely low serum prolactin in two cases of invasive macroprolactinoma. Pituitary 5(4):261–265. https://doi.org/10.1023/a:1025334001748
doi: 10.1023/a:1025334001748
pubmed: 14558675
Pejman Sani M, Ebrahimpur M, Mohajeri-Tehrani MR (2018) Pituitary macroprolactinoma with mildly elevated serum prolactin: Hook effect. Adv J Emerg Med 2(4):e49. https://doi.org/10.22114/AJEM.v0i0.84
doi: 10.22114/AJEM.v0i0.84
pubmed: 31172112
pmcid: 6548154
Petersenn S (2020) Biochemical diagnosis in prolactinomas: some caveats. Pituitary 23(1):9–15. https://doi.org/10.1007/s11102-019-01024-z
doi: 10.1007/s11102-019-01024-z
pubmed: 31873848
Fleseriu M, Lee M, Pineyro MM, Skugor M, Reddy SK, Siraj ES et al (2006) Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of “hook effect.” J Neurooncol 79(1):41–43. https://doi.org/10.1007/s11060-005-9108-7
doi: 10.1007/s11060-005-9108-7
pubmed: 16598425
Toini A, Dolci A, Ferrante E, Verrua E, Malchiodi E, Sala E et al (2015) Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma. Eur J Endocrinol 172(4):363–369. https://doi.org/10.1530/EJE-14-0599
doi: 10.1530/EJE-14-0599
pubmed: 25722096
Strickland BA, Shahrestani S, Briggs RG, Jackanich A, Tavakol S, Hurth K et al (2021) Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. J Neurosurg. https://doi.org/10.3171/2020.10.JNS203236
doi: 10.3171/2020.10.JNS203236
pubmed: 34952511
Langlois F, Lim DST, Yedinak CG, Cetas I, McCartney S, Cetas J et al (2018) Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary 21(1):32–40. https://doi.org/10.1007/s11102-017-0844-4
doi: 10.1007/s11102-017-0844-4
pubmed: 29032459
Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K, Takano K et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61(3):580–584. https://doi.org/10.1227/01.NEU.0000290906.53685.79
doi: 10.1227/01.NEU.0000290906.53685.79
pubmed: 17881972
Chanson P, Raverot G, Castinetti F, Cortet-Rudelli C, Galland F, Salenave S et al (2015) Management of clinically non-functioning pituitary adenoma. Ann Endocrinol (Paris) 76(3):239–247. https://doi.org/10.1016/j.ando.2015.04.002
doi: 10.1016/j.ando.2015.04.002
Beyer-Westendorf J, Bauersachs R, Hach-Wunderle V, Zotz RB, Rott H (2018) Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy. Vasa 47(6):441–450. https://doi.org/10.1024/0301-1526/a000726
doi: 10.1024/0301-1526/a000726
pubmed: 30008249
Fleseriu M, Hoffman AR, Katznelson L, Neuroendocrine A, Pituitary SC (2015) American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: management of acromegaly patients: what is the role of pre-operative medical therapy? Endocr Pract 21(6):668–673. https://doi.org/10.4158/EP14575.DSCR
doi: 10.4158/EP14575.DSCR
pubmed: 26135961
Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al (2021) A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1):1–13. https://doi.org/10.1007/s11102-020-01091-7
doi: 10.1007/s11102-020-01091-7
pubmed: 33079318
Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S et al (2018) Preoperative medical treatment in Cushing’s syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN. Eur J Endocrinol 178(4):399–409. https://doi.org/10.1530/EJE-17-0997
doi: 10.1530/EJE-17-0997
pubmed: 29440375
Kim EH, Oh MC, Lee EJ, Kim SH (2012) Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly. Neurosurgery 70(5):1106–1113. https://doi.org/10.1227/NEU.0b013e31823f5c16
doi: 10.1227/NEU.0b013e31823f5c16
pubmed: 22067418
Zielinski G, Ozdarski M, Maksymowicz M, Szamotulska K, Witek P (2020) Prolactinomas: prognostic factors of early remission after transsphenoidal surgery. Front Endocrinol (Lausanne) 11:439. https://doi.org/10.3389/fendo.2020.00439
doi: 10.3389/fendo.2020.00439
Amlashi FG, Swearingen B, Faje AT, Nachtigall LB, Miller KK, Klibanski A et al (2015) Accuracy of late-night salivary cortisol in evaluating postoperative remission and recurrence in Cushing’s disease. J Clin Endocrinol Metab 100(10):3770–3777. https://doi.org/10.1210/jc.2015-2107
doi: 10.1210/jc.2015-2107
pubmed: 26196950
Danet-Lamasou M, Asselineau J, Perez P, Vivot A, Nunes ML, Loiseau H et al (2015) Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing’s disease following pituitary surgery. Clin Endocrinol (Oxf) 82(2):260–266. https://doi.org/10.1111/cen.12534
doi: 10.1111/cen.12534
Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS et al (2017) Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a Pituitary Society Statement. Pituitary 20(5):489–498. https://doi.org/10.1007/s11102-017-0838-2
doi: 10.1007/s11102-017-0838-2
pubmed: 28884415
pmcid: 5606938